Vanda Pharmaceuticals reported $63.3M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 124.93M 14.92M
Akebia Therapeutics AKBA:US $ 40.95M 32.42M
Alnylam Pharmaceuticals ALNY:US $ 154.97M 35.33M
Anika Therapeutics ANIK:US $ 23.02M 2.21M
AstraZeneca AZN:LN 6.04B 15M
Bluebird Bio BLUE:US $ 2.97M 10.8M
Bristol Myers Squibb BMY:US $ 9333M 81M
Clovis Oncology CLVS:US $ 28.07M 0.88M
Eli Lilly And LLY:US $ 5342M 555.1M
Esperion Therapeutics ESPR:US $ 8.85M 30.01M
Halozyme Therapeutics HALO:US $ 97.24M 16.2M
Insmed INSM:US $ 36.57M 2.04M
Intercept Pharmaceuticals ICPT:US $ 92.17M 3.79M
Johnson & Johnson JNJ:US $ 16088M 343M
Lexicon Pharmaceuticals LXRX:US 23K 211K
Ligand Pharmaceuticals LGND:US $ 53.39M 0.69M
Merk MRK:US $ 10098M 1738M
Moderna Inc MRNA:US 4.25B 643M
Novartis NVS:US $ 9519M 21M
Pfizer PFE:US $ 14163M 2178M
Ptc Therapeutics PTCT:US $ 132.2M 22.89M
Puma Biotechnology PBYI:US $ 35.97M 5.45M
Takeda 4502:JP Y 569023M 139316M
Teva Pharmaceutical TEVA:IT 1.9B 25M
Ultragenyx Pharmaceutical RARE:US $ 77.47M 6.37M
Vanda Pharmaceuticals VNDA:US $ 63.3M 1.96M
Veracyte VCYT:US $ 38.73M 1.09M